Drug maker, Lupin Ltd said that it has received US FDA approval for generic Flagyl® Tablets 250 mg and 500 mg.
“The company has received final approval for its Metronidazole Tablets USP, 250 mg and 500 mg from United States Food and Drug Administration (US FDA) to market a generic version of G.D. Searle LLC’s Flagyl® Tablets 250 mg and 500 mg,” it said in a filing to the Bombay Stock Exchange.
Lupin’s Metronidazole Tablets USP, 250 mg and 500 mg are the AB rated generic equivalent of G.D. Searle LLC’s Flagyl® Tablets 250 mg and 500 mg, it said.
The drug is indicated in the treatment of wide variety of infections which are caused by particular type of bacteria and other infectious organisms.
According to IMS MAT June 2017, Flagyl® Tablets has US sales of USD 44.1 million.
Meanwhile, shares of the company closed trading at Rs 992.10 apiece, up 1.10 per cent from the previous close on BSE.